Great Point Partners LLC Viking Therapeutics, Inc. Transaction History

Great Point Partners LLC

  • $377 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$14.84 - $24.79 $5.96 Million - $9.95 Million
-401,450 Reduced 40.14%
598,550 $9.7 Million
Q1 2023

May 15, 2023
SELL
$8.08 - $17.33 $2.38 Million - $5.11 Million
-295,034 Reduced 22.78%
1,000,000 $16.6 Million
Q4 2022

Feb 14, 2023
BUY
$2.72 - $9.4 $3.52 Million - $12.2 Million
1,295,034 New
1,295,034 $12.2 Million

Others Institutions Holding VKTX

# of Institutions
478
Shares Held
66.1M
Call Options Held
6.24M
Put Options Held
3.01M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.05B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email